Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.
Press releases published on May 16, 2025

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American…
Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes CMP-SYNGAP-01 administration led to a significant increase in SYNGAP1 protein …

New Casino Sites UK – Aztec Paradise Picked as The Newest
SAN JOSÉ, Costa Rica, May 16, 2025 (GLOBE NEWSWIRE) -- The online gambling world is constantly evolving, and every year new casino sites are launched in the UK. These new platforms often come with fresh ideas, innovative features, and enticing bonuses to …

Bitget oznamuje strategické partnerství s ekosystémem SWEAT s cílem posílit pohybovou ekonomiku v prostředí Web3
DUBAJ, Spojené Arabské Emiráty, May 16, 2025 (GLOBE NEWSWIRE) -- Bitget, přední kryptoměnová burza a společnost zaměřená na Web3, oznámila strategické partnerství s průkopnickým ekosystémem pohybové ekonomiky SWEAT, který snižuje vstupní bariéry pro …

CoinEx Charity Connects IFRI in Benin to High-Speed Internet via Starlink, Advancing Digital Equity through the “Bridge to Hope” Initiative
HONG KONG, May 16, 2025 (GLOBE NEWSWIRE) -- As the digital divide continues to pose significant challenges to educational development across many parts of Africa, CoinEx Charity is actively advancing its global philanthropic initiative, “Bridge to Hope,” …

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …